Through my post-doctoral training, I am focusing on developing clinical pharmacology expertise in HIV antiretrovirals and anti-Parkinson medications. My research interests are in drug-drug interactions caused by inflammation and polypharmacy. Ultimately, my research aims to identify factors of pharmacokinetic and pharmacodynamic variability in order to develop safer strategies of medication administration in populations vulnerable to drug-drug interactions.
